Why don’t cancer patients enter clinical trials? A review
- 1 August 2006
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (12) , 1744-1748
- https://doi.org/10.1016/j.ejca.2005.10.033
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The Study of Accrual to Clinical Trials: Can We Learn From Studying Who Enters Our Studies?Journal of Clinical Oncology, 2004
- Patient entry into randomized controlled trials of colorectal cancer treatment: Factors influencing participationSurgery, 2003
- Views of American Oncologists About the Purposes of Clinical TrialsJNCI Journal of the National Cancer Institute, 2002
- Informing breast cancer patients about clinical trials:a randomized clinical trial of an educational bookletAnnals of Oncology, 2002
- Randomized Clinical Trials in Oncology: Understanding and Attitudes Predict Willingness to ParticipateJournal of Clinical Oncology, 2001
- Reasons for accepting or declining to participate in randomized clinical trials for cancer therapyBritish Journal of Cancer, 2000
- Entry into clinical trials in breast cancer: the importance of specialist teamsEuropean Journal Of Cancer, 1998
- Clinicians' attitudes to clinical trials of cancer therapyEuropean Journal Of Cancer, 1997
- Physicians' attitudes toward clinical trials and their relationship to patient accrual in a nordic multicenter study on myelomaControlled Clinical Trials, 1996
- Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators.Journal of Clinical Oncology, 1994